Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background

Acute Pancreatitis (AP) is an uncommon complication that rarely occurs during Rheumatoid Arthritis (RA). Among the varied etiologies of AP, Drug-induced Pancreatitis (DIP) remains a rare entity and a rather challenging condition. A large panel of drugs have been reported to cause pancreatitis; however, there are no cases of tofacitinib-induced pancreatitis reported in the literature.

Case Presentation

We have, herein, reported the case of a Tunisian 58-year-old woman with a four-year history of RA who experienced two episodes of AP; the first one occurred on the second day of a 3-day series of methylprednisolone intravenous injections, and the second episode occurred on the sixth-day of tofacitinib administration. Each time, she presented acute abdominal pain with characteristic radiation to the back. Symptoms resolved spontaneously once the suspected drug was discontinued. In the event of a negative investigation, including abdominal ultrasonography and magnetic resonance imaging, and assessment of albumin, calcemia, triglyceridemia, serum ferritin, and IgG4 levels, DIP was the most likely diagnosis.

Conclusion

Although DIP is still a rare condition, it remains serious with an increased risk of mortality. We intended to alert clinicians that in addition to the known side effects of tofacitinib, pancreatitis may be induced by this drug, especially in predisposed patients.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863300565240819114551
2024-09-04
2025-10-25

  • From This Site

    /content/journals/cds/10.2174/0115748863300565240819114551
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TrivediC.D. PitchumoniC.S. Drug-Induced Pancreatitis.J. Clin. Gastroenterol.200539870971610.1097/01.mcg.0000173929.60115.b4 16082282
     [Google Scholar]
  2. JonesM.R. HallO.M. KayeA.M. KayeA.D. Drug-induced acute pancreatitis: A review.Ochsner J.20151514551 25829880
     [Google Scholar]
  3. BadalovN. BaradarianR. IswaraK. LiJ. SteinbergW. TennerS. Drug-induced acute pancreatitis: An evidence-based review.Clin. Gastroenterol. Hepatol.200756648661.e310.1016/j.cgh.2006.11.023 17395548
     [Google Scholar]
  4. MalloryA. KernF.Jr Drug-induced pancreatitis: A critical review.Gastroenterology198078481382010.1016/0016‑5085(80)90689‑7 6986321
     [Google Scholar]
  5. McARTHUR KE. Review article: Drug‐induced pancreatitis.Aliment. Pharmacol. Ther.1996101233810.1111/j.1365‑2036.1996.tb00174.x 8871441
     [Google Scholar]
  6. NitscheC.J. JamiesonN. LerchM.M. MayerleJ.V. Drug induced pancreatitis.Best Pract. Res. Clin. Gastroenterol.201024214315510.1016/j.bpg.2010.02.002 20227028
     [Google Scholar]
  7. FeligD.M. TopazianM. Corticosteroid-induced pancreatitis.Ann. Intern. Med.199612411101610.7326/0003‑4819‑124‑11‑199606010‑00018 8624057
     [Google Scholar]
  8. UnderwoodT.W. FryeC.B. Drug-induced pancreatitis.Clin. Pharm.1993126440448 8403815
     [Google Scholar]
  9. WeissmanS. AzizM. PerumpailR.B. MehtaT.I. PatelR. TabibianJ.H. Ever-increasing diversity of drug-induced pancreatitis.World J. Gastroenterol.202026222902291510.3748/wjg.v26.i22.2902 32587438
     [Google Scholar]
  10. WolfeD. KanjiS. YazdiF. BarbeauP. RiceD. BeckA. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.PLoS One2020154e023188310.1371/journal.pone.0231883
     [Google Scholar]
  11. DwivediP. KumarR.R. DhooriaA. Corticosteroid-associated lupus pancreatitis: A case series and systematic review of the literature.Lupus201928673173910.1177/0961203319844004 31023131
     [Google Scholar]
  12. MorinobuA. JAK inhibitors for the treatment of rheumatoid arthritis.Immunol. Med.202043414815510.1080/25785826.2020.1770948 32501149
     [Google Scholar]
  13. BollenT.L. Acute pancreatitis: International classification and nomenclature.Clin. Radiol.201671212113310.1016/j.crad.2015.09.013 26602933
     [Google Scholar]
  14. BalthazarE.J. Acute pancreatitis: Assessment of severity with clinical and CT evaluation.Radiology2002223360361310.1148/radiol.2233010680 12034923
     [Google Scholar]
  15. ChangC.C. ChiouC.S. LinH.L. WangL.H. ChangY.S. LinH.C. Increased risk of acute pancreatitis in patients with rheumatoid arthritis: A population-based cohort study.PLoS One2015108e013518710.1371/journal.pone.0135187 26262880
     [Google Scholar]
  16. ZhengJ. YangQ.J. DangF.T. YangJ. Drug-induced pancreatitis: An update.Arab J Gastroenterol Off Publ Pan-Arab Assoc Gastroenterol2019204183188 31806409
     [Google Scholar]
  17. CaiW. TongR. SunY. YaoY. ZhangJ. Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: A systematic review and network meta-analysis of randomized controlled trials.Front. Pharmacol.202415138758510.3389/fphar.2024.1387585 38725657
     [Google Scholar]
  18. KuboS. NakayamadaS. TanakaY. JAK inhibitors for rheumatoid arthritis.Expert Opin. Investig. Drugs202332433334410.1080/13543784.2023.2199919 37014106
     [Google Scholar]
  19. YtterbergS.R. BhattD.L. MikulsT.R. Cardiovascular and cancer risk with Tofacitinib in rheumatoid arthritis.N. Engl. J. Med.2022386431632610.1056/NEJMoa2109927 35081280
     [Google Scholar]
  20. FlaigT. DourosA. BronderE. KlimpelA. KreutzR. GarbeE. Tocilizumab-induced pancreatitis: Case report and review of data from the FDA Adverse Event Reporting System.J. Clin. Pharm. Ther.201641671872110.1111/jcpt.12456 27670839
     [Google Scholar]
  21. KamathA. AcharyaS.D. RaoR.R. UllalS.D. Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database.Sci. Rep.20211111881810.1038/s41598‑021‑98325‑w 34552181
     [Google Scholar]
  22. JonesG DingC. Tocilizumab: A review of its safety and efficacy in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord20103CMAMD.S4864.10.4137/CMAMD.S4864 21234291
     [Google Scholar]
  23. FortsonM.R. FreedmanS.N. WebsterP.D.III Clinical assessment of hyperlipidemic pancreatitis.Am. J. Gastroenterol.1995901221342139 8540502
     [Google Scholar]
  24. LevineR.A. McGuireR.F. Corticosteroid-induced pancreatitis: A case report demonstrating recurrence with rechallenge.Am. J. Gastroenterol.1988831011611164 3421228
     [Google Scholar]
  25. SashL. Relationship of cortisone therapy to pancreatic necrosis.BMJ19592515686786810.1136/bmj.2.5156.867 14441865
     [Google Scholar]
  26. ZionM.M. GoldbergB. SuzmanM.M. Corticotrophin and cortisone in the treatment of scleroderma.Q. J. Med.19552495215227 13266985
     [Google Scholar]
  27. FreyC. RedoS.F. Inflammatory lesions of the pancreas in infancy and childhood.Pediatrics19633219310210.1542/peds.32.1.93 13959629
     [Google Scholar]
  28. TilneyN.L. CollinsJ.J.Jr WilsonR.E. Hemorrhagic Pancreatitis.N. Engl. J. Med.1966274191051105710.1056/NEJM196605122741903 5326140
     [Google Scholar]
  29. NelpW.B. Acute pancreatitis associated with steroid therapy.Arch. Intern. Med.1961108570271010.1001/archinte.1961.03620110042007 14478884
     [Google Scholar]
  30. MeltzerL. PalmonF.P.Jr PaikY.K. CusterR.P. Acute pancreatitis secondary to hypercalcemia of multiple myeloma.Ann. Intern. Med.19625761008101210.7326/0003‑4819‑57‑6‑1008 13934757
     [Google Scholar]
  31. SteinbergW.M. LewisJ.H. Steroid-induced pancreatitis: Does it really exist?Gastroenterology198181479980810.1016/0016‑5085(81)90511‑4 7021304
     [Google Scholar]
  32. BaarH. WolffO.H. Pancreatic necrosis in cortisone-treated children.Lancet1957269697381281510.1016/S0140‑6736(57)90974‑1 13417603
     [Google Scholar]
  33. GulloL. MiglioriM. OláhA. Acute pancreatitis in five European countries: Etiology and mortality.Pancreas200224322322710.1097/00006676‑200204000‑00003 11893928
     [Google Scholar]
  34. KlöppelG. MailletB. Chronic pancreatitis: Evolution of the disease.Hepatogastroenterology1991385408412 1765357
     [Google Scholar]
/content/journals/cds/10.2174/0115748863300565240819114551
Loading
Tofacitinib-Induced Acute Pancreatitis in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature
Curr Drug Saf 20, 366 (2025); https://doi.org/10.2174/0115748863300565240819114551
/content/journals/cds/10.2174/0115748863300565240819114551
/content/journals/cds/10.2174/0115748863300565240819114551
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): adverse effects; Case report; corticosteroids; drug-induced pancreatitis; janus kinase inhibitors; pancreatitis; rheumatoid arthritis; tofacitinib

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test